Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2011 2
2017 2
2018 4
2019 4
2020 11
2021 12
2022 10
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for shan fei liu
Search for Shanfei Liu instead (1 results)
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, Liu D, Lou H, Bai L, Liu T, Li Y, Li Y, Fan Q, Feng M, Zhong H, Huang Y, Lou G, Wang J, Lin X, Chen Y, An R, Li C, Zhou Q, Huang X, Guo Z, Wang S, Li G, Fei J, Zhu L, Zhu H, Li X, Li F, Liao S, Min Q, Tang L, Shan F, Gong J, Gao Y, Zhou J, Lu Z, Li X, Li J, Ren H, Liu X, Yang H, Li W, Song W, Wang ZM, Li B, Xia M, Wu X, Ji J. Gao X, et al. Among authors: shan f. Lancet Oncol. 2023 Oct;24(10):1134-1146. doi: 10.1016/S1470-2045(23)00411-4. Lancet Oncol. 2023. PMID: 37797632 Clinical Trial.
Chinese expert consensus on imaging diagnosis of drug-resistant pulmonary tuberculosis.
Xu CJ, Lu PX, Li CH, He YL, Fang WJ, Xie RM, Jin GQ, Lu YB, Zheng QT, Zheng GP, Lv SX, Huang H, Li L, Ren M, Shi YX, Wen XN, Li L, Wei FJ, Hou DL, Lv Y, Shan F, Wu ZC, Hu ZL, Zhang XR, Liu DX, Shi WY, Li HR, Zhang N, Song M, Zhang X, Deng YY, Li J, Liu Q, Li D, Zhao L, Chen BD, Shi YB, Jiang FL, Tang X, Wu LJ, Ma W, Xu XY, Li HJ. Xu CJ, et al. Among authors: shan f. Quant Imaging Med Surg. 2024 Jan 3;14(1):1039-1060. doi: 10.21037/qims-23-1223. Epub 2023 Oct 25. Quant Imaging Med Surg. 2024. PMID: 38223121 Free PMC article. Review.
Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression.
Yang S, Ling Y, Zhao F, Li W, Song Z, Wang L, Li Q, Liu M, Tong Y, Chen L, Ru D, Zhang T, Zhou K, Zhang B, Xu P, Yang Z, Li W, Song Y, Xu J, Zhu T, Shan F, Yu W, Lu H. Yang S, et al. Among authors: shan f. Signal Transduct Target Ther. 2022 Mar 18;7(1):91. doi: 10.1038/s41392-022-00952-w. Signal Transduct Target Ther. 2022. PMID: 35304437 Free PMC article.
Epidemiology and clinical course of COVID-19 in Shanghai, China.
Shen Y, Zheng F, Sun D, Ling Y, Chen J, Li F, Li T, Qian Z, Zhang Y, Xu Q, Liu L, Huang Q, Shan F, Xu L, Wu J, Zhu Z, Song Z, Li S, Shi Y, Zhang J, Wu X, Mendelsohn JB, Zhu T, Lu H. Shen Y, et al. Among authors: shan f. Emerg Microbes Infect. 2020 Dec;9(1):1537-1545. doi: 10.1080/22221751.2020.1787103. Emerg Microbes Infect. 2020. PMID: 32573353 Free PMC article.
52 results